Disc Medicine is a developer of medicines for hematologic diseases with three clinical-stage candidates. IRON's lead candidate, bitopertin, is currently in phase 2 trials targeting erythropoietic ...
Positive results have already been released from the BEACON study, whereby treatment with bitopertin of patients with EPP/XLP showed reduction of PPIX levels and improvement of quality of life. The ...
The rare earths are a group of 17 metallic elements that find their way into products and industries from smartphones to fighter jets. Powerful, compact motors sporting magnets made from rare-earth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback